- Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon
- Author: Mr Mfazo Hove
- Published: April 11, 2025
- Last Updated: October 5, 2026
TL;DR: Cataract Surgery vs YAG Laser Capsulotomy compares two distinct treatments used at different stages of care. Cataract surgery removes the cloudy natural lens and replaces it with an artificial lens, while YAG laser capsulotomy treats clouding of the lens capsule that can develop months or years later.
Cataract Surgery and YAG Laser Capsulotomy Explained
Cataracts and posterior capsule opacification (PCO) are related but distinct conditions.
Cataract surgery removes the cloudy natural lens and replaces it with an artificial intraocular lens (IOL). Months or years later, some patients develop PCO, which is clouding of the residual lens capsule that holds the IOL. This can produce symptoms similar to the original cataract.
YAG laser capsulotomy is the standard treatment for visually significant PCO, meaning clouding that noticeably affects sight.¹ At Blue Fin Vision®, both procedures are provided within a consultant-led pathway.
What Is Cataract Surgery?
Cataract surgery removes the cloudy natural lens and implants a clear artificial IOL.
It is one of the most commonly performed operations in medicine. The procedure is carried out under topical anaesthesia, meaning numbing eye drops, as a day-case procedure that does not usually require an overnight hospital stay.²
In Mr Mfazo Hove’s routine practice, the surgical component commonly takes approximately four to six minutes per eye, although complex cases appropriately take longer.
The complete hospital visit includes admission, preparation, dilation and discharge. It is therefore considerably longer than the operation itself.
What Is YAG Laser Capsulotomy?
YAG laser capsulotomy is a non-incisional outpatient laser treatment used to treat posterior capsule opacification after cataract surgery or refractive lens exchange.
The neodymium-doped yttrium aluminium garnet (Nd:YAG) laser delivers focused energy to create a precise central opening in the cloudy posterior capsule. This allows light to pass through with less scattering.¹
YAG laser capsulotomy does not remove or replace the intraocular lens. A cataract cannot return once the natural lens has been removed. PCO is a separate process involving residual lens epithelial cells, meaning cells left behind after lens surgery.
The laser application itself usually lasts only a few minutes.
Patients should generally allow approximately 30–60 minutes for the complete appointment. This includes assessment, dilation and any pressure checks required to measure intraocular pressure, meaning the pressure inside the eye.
Key Differences: Cataract Surgery vs YAG Laser Capsulotomy
- Purpose: Cataract surgery treats the cloudy natural lens. YAG laser capsulotomy treats the residual lens capsule after lens surgery.
- Technique: Cataract surgery requires a micro-incision, meaning a very small surgical opening. YAG laser capsulotomy is non-incisional.
- Timing: Cataract surgery is the primary procedure. YAG laser capsulotomy is considered only if visually significant PCO develops later.
- Recovery: Cataract surgery settles over days to weeks. After YAG laser capsulotomy, most patients resume ordinary activities on the same day or the following day once the dilation has worn off.
When Might You Need Both?
With sufficiently long follow-up, some degree of posterior capsule opacification develops in almost every eye following cataract surgery or refractive lens exchange.
However, it does not always become visually significant or require treatment. YAG laser capsulotomy is considered only when the opacity meaningfully affects vision or visual quality and the clinical findings correspond with the patient’s symptoms.³ ⁴
Before any YAG treatment at Blue Fin Vision®, every patient receives a macular optical coherence tomography (OCT) scan at no additional charge. This is a detailed scan of the macula, the central part of the retina responsible for detailed vision.
The scan is interpreted alongside visual testing and a full clinical examination. Our companion article, Why Blue Fin Vision® Performs a Macular OCT Scan Before Every YAG Capsulotomy, explains this policy in full.
Choosing the Appropriate Treatment
Where PCO is responsible for the symptoms, vision can often be restored with a brief, non-incisional laser treatment.¹
A thorough assessment determines whether posterior capsule opacification is the most likely cause of the symptoms and whether treatment is likely to help.
Book a paid, consultant-led consultation with Blue Fin Vision® in London, Hertfordshire or Essex to determine whether cataract surgery, YAG laser capsulotomy or another form of treatment is appropriate for your eyes.
References
- Karahan E, Er D, Kaynak S. An overview of Nd:YAG laser capsulotomy. Med Hypothesis Discov Innov Ophthalmol. 2014;3(2):45-50.
- Chen SP, Woreta F, Chang DF. Cataracts: a review. JAMA. 2025;333(23):2093-2103.
- Schaumberg DA, Dana MR, Christen WG, Glynn RJ. A systematic overview of the incidence of posterior capsule opacification. Ophthalmology. 1998;105(7):1213-1221.
- Awasthi N, Guo S, Wagner BJ. Posterior capsular opacification: a problem reduced but not yet eradicated. Arch Ophthalmol. 2009;127(4):555-562.
ABOUT THE AUTHOR
Mr Mfazo Hove
MBChB MD FRCOphth CertLRS
Consultant Ophthalmic Surgeon | Founder and Medical Director, Blue Fin Vision®
Mr Mfazo Hove is a Consultant Ophthalmic Surgeon with more than two decades of experience across NHS and private practice and more than 57,000 ophthalmic procedures performed. He trained for six and a half years at Moorfields Eye Hospital and served for five years as an NHS consultant at the Western Eye Hospital, Imperial College Healthcare NHS Trust.
He specialises in cataract surgery, refractive lens replacement, laser vision correction and implantable Collamer lenses (ICL). He is the founder and Medical Director of Blue Fin Vision®, a private ophthalmology group providing consultant-delivered care across London, Hertfordshire and Essex. His cataract surgery outcomes are publicly reported through the National Ophthalmology Database.
A ZEISS Key Opinion Leader and international speaker, Mr Hove is a contributing author to The Ophthalmologist. His writing examines how clinical governance and the organisation of ophthalmic services shape patients’ experiences and outcomes, with a focus on transparent outcome reporting, surgical training and long-term accountability for patient care.
